REPORTING LIVE FROM THE SPOCK NEWS DESK
IN THE VIRTUAL JASPER JOTTINGS NEWSROOM …
http://www.spock.com/John-Amedio-jhmaI1xw
Amedio, John [MC1982]
# – # – #
John Amedio , PhD Vice President, Manufacturing & Process Development Dr. Amedio is Vice President, Manufacturing & Process Development, serving in this capacity since 2006. Dr. Amedio has seventeen years of experience in major and start-up pharmaceutical companies. ziopharm
# – # – #
[JR: Which led to!]
John Amedio, Ph.D.
Vice President, Manufacturing & Process Development
Dr. Amedio is Vice President, Manufacturing & Process Development, serving in this capacity since 2006. Dr. Amedio has seventeen years of experience in major and start-up pharmaceutical companies. He has extensive experience in all aspects of Chemistry, Manufacturing and Controls (CMC), including regulatory agency document preparation, active pharmaceutical ingredient synthesis, drug product pre-formulation and formulation, analytical methods development and the preparation of clinical trial materials. Most recently Dr. Amedio was Executive Director, Analytical and Chemical R&D, EPIX Pharmaceuticals, Cambridge, MA. Before joining EPIX in 1995, Dr. Amedio was with Sandoz Research Institute (currently Novartis Pharmaceuticals), East Hanover, New Jersey, as a Unit Leader in the Chemical Research and Development department.
# – # – #
[JR: Which led to!]
http://www.linkedin.com/pub/5/a1/945
John Amedio
John is a 3rd degree contact
VP, Manufacturing and Process Development at ZIOPHARM Oncology
Location
Greater Boston Area
Industry
Pharmaceuticals
Current
* VP, Manufacturing and Process Development at ZIOPHARM Oncology
Education
* Manhattan College
Connections
3 connections
Public Profile
http://www.linkedin.com/pub/5/a1/945
Applications
Experience
VP, Manufacturing and Process Development
ZIOPHARM Oncology
Public Company; Pharmaceuticals industry
Currently holds this position
Education
Manhattan College
1978 – 1982
# – # – #
ZIOPHARM Appoints John Amedio, Ph.D. as Vice President, Manufacturing & Process Development
Company Fills Key Position in Anticipation of Pivotal Clinical Trials
NEW YORK–(BUSINESS WIRE)–Sept. 22, 2006–ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today the appointment of John Amedio, Ph.D., as Vice President, Manufacturing & Process Development. Dr. Amedio joins ZIOPHARM with over 17 years of drug development experience in both major pharmaceutical and early stage biotechnology companies. John has a Ph.D. in organic chemistry and he is an adjunct professor in the Department of Pharmaceutical Sciences at the Massachusetts College of Pharmacy and Health Sciences Boston, where he teaches Good Manufacturing Practices Compliance.
John’s extensive experience in chemistry, manufacturing and control (CMC), analytical and process development, and formulation development will be critical for ZIOPHARM as the Company moves toward manufacturing scale-up in anticipation of late stage clinical trials for its lead programs, ZIO-101 and ZIO-201. Prior to joining ZIOPHARM John spent 10 years at EPIX Pharmaceuticals where he was most recently Executive Director, Chemical and Analytical Research & Development. John was with Sandoz Pharmaceuticals (now part of Novartis Pharmaceuticals) prior to joining EPIX.
“Dr. Amedio joins ZIOPHARM at a critical juncture in the Company’s evolution as we move from small scale production of material for early clinical trials to the large batches required for pivotal studies,” said Jon Lewis, CEO. “John’s experience and leadership will be key for us as we ramp up production of our lead drugs, ZIO-101 and ZIO-201 and as we acquire additional programs.”
About ZIOPHARM Oncology, Inc.
ZIOPHARM Oncology, Inc. is a biopharmaceutical company
# # # # #
